Assessment of performance of CHROMagar KPC and Xpert Carba-R assay for the detection of carbapenem resistant bacteria in rectal swabs: First comparative study from Abu Dhabi, United Arab Emirates.
The objective of the current study was to evaluate performance of CHROMagar KPC culture compared to Xpert Carba-R molecular method while investigating carbapenem resistance in bacterial isolates from rectal swabs. Rectal swabs were obtained from patients admitted to Cleveland Clinic Abu Dhabi in United Arab Emirates for 7 months and screened for carbapenem resistance by either culture on CHROMagar KPC or testing carbapenemase production using Xpert Carba-R molecular method. Further testing for carbapenem susceptibility for isolates recovered from CHROMagar KPC was performed using Vitek 2. A total of 1831 rectal swabs were screened. Of these, 61 were positive for carbapenem resistance (3.4%) by either one or both methods. Both methods were equally efficient to detect carbapenem resistance in 37 (60.6%) swabs, mostly positive for Klebsiella pneumoniae where 22 isolates were recovered, of which 41% carried blaOXA-48-like and blaNDM. Xpert Carba-R assay detected 12 additional swabs with negative CHROMagar KPC culture, and revealed additional carbapenemase-producing organisms carrying blaOXA-48-like and/or blaNDM. CHROMagar KPC recovered organisms in 9 swabs not detected by genotypic method, 44.4% of which being K. pneumoniae. Three swabs yielded false-positive results in both methods with carbapenem-sensitive organisms. Sensitivity and specificity of CHROMagar KPC were 75.4% and 99.82%, while of Xpert Carba-R were 80% and 99.82% respectively. This comparative study of CHROMagar KPC versus Xpert Carba-R in rectal swabs showed a slightly higher sensitivity for PCR-based method. While CHROMagar KPC provides a less expensive screening method, Xpert Carba-R may be more accurate and faster.